Transgene SA
OTC:TRGNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transgene SA
OTC:TRGNF
|
FR |
|
E
|
EOG Resources Inc
SWB:EO5
|
US |
|
UPM-Kymmene Oyj
OMXH:UPM
|
FI |
|
N
|
News Corp
F:NC0
|
US |
|
Fugro NV
AEX:FUR
|
NL |
|
A
|
Amdocs Ltd
XMUN:AOS
|
GG |
|
Securitas AB
OTC:SCTBF
|
SE |
|
A
|
Autodesk Inc
SWB:AUD
|
US |
|
S
|
Securitas AB
DUS:S7MB
|
SE |
|
F
|
Federal Home Loan Mortgage Corp
OTC:FMCC
|
US |
|
3
|
3M Co
XHAN:MMM
|
US |
|
S
|
Safran SA
DUS:SEJ1
|
FR |
|
S
|
SoftBank Group Corp
OTC:SFTBY
|
JP |
|
A
|
AMETEK Inc
XMUN:AK1
|
US |
Bankruptcy Probability
Transgene SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Transgene SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Transgene SA
PAR:TNG
|
234.2m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Transgene SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Transgene SA has total debt of 1.7m EUR. This includes both short-term (0 EUR) and long-term (1.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.